Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Terunuma Website

Atsushi Terunuma, M.D., Ph.D.

Selected Publications
1)  Xiao Y, Woo WM, Nagao K, Li W, Terunuma A, Mukouyama YS, Oro AE, Vogel JC, Brownell I.
Perivascular Hair Follicle Stem Cells Associate with a Venule Annulus.
J. Invest. Dermatol. 2013. [Journal]
2)  Miyagawa F, Zhang H, Terunuma A, Ozato K, Tagaya Y, Katz SI.
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells.
Proceedings of the National Academy of Sciences of the United States of America. 2012. [Journal]
3)  Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B.
Relationship between Tumor DNA Methylation Status and Patient Characteristics in African-American and European-American Women with Breast Cancer.
PLoS ONE. 7: e37928, 2012. [Journal]
4)  Patel GK, Yee CL, Terunuma A, Telford WG, Voong N, Yuspa SH, Vogel JC.
Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma.
J. Invest. Dermatol. 132: 401-9, 2012. [Journal]
5)  Terunuma A.
Understanding microarrays: DNA gene-expression microarray as a tool to characterize all genes expressed in human skin (Update for Chapter 8). In: Fitzpatrick's Dermatology in General Medicine, 7th Edition.
New York: McGraw-Hill; 2011. p. AccessMedicine 1001749 [Book Chapter]
6)  Tock CL, Turner LR, Altiner A, Batra P, Booher SL, Coelho SG, Warner JA, Therrien JP, Turner ML, Miller SA, Beer JZ, Kraemer KH, Udey MC, Vogel JC, Terunuma A.
Transcriptional signatures of full-spectrum and non-UVB-spectrum solar irradiation in human skin.
Pigment cell & melanoma research. 2011. [Journal]
7)  Terunuma A, Limgala RP, Park CJ, Choudhary I, Vogel JC.
Efficient procurement of epithelial stem cells from human tissue specimens using a rho-associated protein kinase inhibitor Y-27632.
Tissue Eng Part A. 16: 1363-8, 2010. [Journal]
8)  Therrien JP, Kim SM, Terunuma A, Qin Y, Tock CL, Pfützner W, Ohyama M, Schnermann J, Vogel JC.
A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin grafts.
Proc. Natl. Acad. Sci. U.S.A. 107: 1178-83, 2010. [Journal]
9)  Terunuma A, Cross JW, Dyke M, Kapoor V, Telford WG, Vogel JC.
Behavior of human foreskin keratinocytes expressing a hair follicle stem cell marker CD200.
J. Invest. Dermatol. 128: 1332-4, 2008. [Journal]
10)  Terunuma A, Kapoor V, Yee C, Telford WG, Udey MC, Vogel JC.
Stem cell activity of human side population and alpha-6 integrin-bright keratinocytes defined by a quantitative in vivo assay.
Stem Cells. 25: 664-9, 2007. [Journal]
11)  Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC.
Characterization and isolation of stem cell-enriched human hair follicle bulge cells.
J Clin Invest. 116: 249-60, 2006. [Journal]
12)  Terunuma A, Shaya MB, Udey MC, Vogel JC.
An in vivo competitive repopulation assay system to evaluate human keratinocyte stem cells.
J Invest Dermatol. 123: 993-5, 2004. [Journal]
13)  Blonder J, Terunuma A, Conrads TP, Chan KC, Yee C, Lucas DA, Schaefer CF, Yu LR, Issaq HJ, Veenstra TD, Vogel JC.
A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry.
J Invest Dermatol. 123: 691-9, 2004. [Journal]
14)  Terunuma A, Ye J, Emmert S, Khan SG, Kraemer KH, Vogel JC.
Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes.
Gene Ther. 11: 1729-34, 2004. [Journal]
15)  Blonder J, Conrads TP, Yu LR, Terunuma A, Janini GM, Issaq HJ, Vogel JC, Veenstra TD.
A detergent- and cyanogen bromide-free method for integral membrane proteomics: application to Halobacterium purple membranes and the human epidermal membrane proteome.
Proteomics. 4: 31-45, 2004. [Journal]
16)  Terunuma A, Jackson KL, Kapoor V, Telford WG, Vogel JC.
Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells.
J Invest Dermatol. 121: 1095-103, 2003. [Journal]
17)  Hoang VM, Conrads TP, Veenstra TD, Blonder J, Terunuma A, Vogel JC, Fisher RJ.
Quantitative proteomics employing primary amine affinity tags.
J Biomol Tech. 14: 216-23, 2003. [Journal]
18)  Pfutzner W, Terunuma A, Tock CL, Snead EK, Kolodka TM, Gottesman MM, Taichman L, Vogel JC.
Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo.
Proc Natl Acad Sci U S A. 99: 13096-101, 2002. [Journal]
19)  Kuhn U, Terunuma A, Pfutzner W, Foster RA, Vogel JC.
In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.
J Virol. 76: 1496-504, 2002. [Journal]
20)  Terunuma A, Aiba S, Tagami H.
Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant.
J Dermatol Sci. 26: 85-93, 2001. [Journal]
21)  Terui T, Takahashi K, Funayama M, Terunuma A, Ozawa M, Sasai S, Tagami H.
Occurrence of neutrophils and activated Th1 cells in UVB-induced erythema.
Acta Derm Venereol. 81: 8-13, 2001. [Journal]
22)  Terunuma A, Watabe A, Kato T, Tagami H.
Coexistence of vitiligo and sarcoidosis in a patient with circulating autoantibodies.
Int J Dermatol. 39: 551-3, 2000. [Journal]
23)  Terui T, Funayama M, Terunuma A, Takahashi K, Tagami H.
Ultraviolet B radiation exerts enhancing effects on the production of a complement component, C3, by interferon-gamma-stimulated cultured human epidermal keratinocytes, in contrast to photochemotherapy and ultraviolet A radiation that show suppressive effects.
Br J Dermatol. 142: 660-8, 2000. [Journal]
24)  Komatsu H, Terunuma A, Tabata N, Tagami H.
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases.
Br J Dermatol. 141: 554-7, 1999. [Journal]
25)  Terunuma A, Shiba K, Noda T.
A novel genetic system to isolate a dominant negative effector on DNA-binding activity of Oct-2.
Nucleic Acids Res. 25: 1984-90, 1997. [Journal]
26)  Aiba S, Terunuma A, Manome H, Tagami H.
Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules.
Eur J Immunol. 27: 3031-8, 1997. [Journal]
27)  Terunuma A, Hashimoto-Kumasaka K, Hirasawa Y, Ogasawara T, Atsumi M.
Multiple skin metastases revealing an esophageal adenocarcinoma.
European Journal of Dermatology. 3: 173-174, 1997. [Journal]
28)  Kudoh K, Kamei E, Terunuma A, Nakagawa S, Tagami H.
Successful treatment of cutaneous sporotrichosis with terbinafine.
Journal of Dermatological Treatment. 7: 33-35, 1996. [Journal]
29)  Terunuma A, Shiba K, Noda T.
Genetic isolation of a human cDNA clone that trans-dominantly inhibits the DNA-binding activity of Oct-2 protein.
Protein Engineering. 8: 77, 1995. [Journal]
30)  Terunuma A, Takahashi K, Sakakibara A, Aiba S, Tagami H.
Annular psoriasiform eruption with lymphocytic infiltration of the epidermis: a variant of acute psoriasis?.
Dermatology. 185: 156-9, 1992. [Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/30/2013.